Dergiler / Diagnostic and Interventional Radiology / 2017 / Cilt: 23 - Sayı: 6

Background parenchymal enhancement: is it just an innocent effect of estrogen on the breast?

Sayfa
414–419
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

High-grade BPE, whether symmetrical or not, is rarely seen in postmenopausal women; hence, these patients should be further investigated or closely followed up

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:PURPOSE We aimed to retrospectively analyze whether background parenchymal enhancement (BPE) on breast magnetic resonance imaging (MRI) correlates with menarche, menopause, reproductive period, menstrual cycle, gravidity-parity, family history of breast cancer, and the Breast Imaging-Reporting and Data System (BI-RADS) category of the patient.
📊
Temel Bulgular & Veri:METHODS The study included 126 pre- and 78 postmenopausal women who underwent breast MRI in our institute between 2011 and 2016.
💡
Sonuç & Katkı:High-grade BPE, whether symmetrical or not, is rarely seen in postmenopausal women; hence, these patients should be further investigated or closely followed up
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:2011 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

PURPOSE We aimed to retrospectively analyze whether background parenchymal enhancement (BPE) on breast magnetic resonance imaging (MRI) correlates with menarche, menopause, reproductive period, menstrual cycle, gravidity-parity, family history of breast cancer, and the Breast Imaging-Reporting and Data System (BI-RADS) category of the patient. METHODS The study included 126 pre- and 78 postmenopausal women who underwent breast MRI in our institute between 2011 and 2016. Patients had filled a questionnaire form before the MRI. Two radiologists blinded to patient history graded the BPEs and the results were compared and analyzed. RESULTS The BPE was correlated with patient age and the day of menstrual cycle (P < 0.01 for both). No correlation was found with menarche age, menopause age, total number of reproductive years, and family history of breast cancer. In the moderate BPE group, only 1 out of 35 patients and in the marked BPE group only 1 out of 13 patients were postmenopausal and had BI-RADS scores of 4 and 5, respectively. CONCLUSION Increased symmetrical BPE is mainly due to current hormonal status in the premenopausal women. High-grade BPE, whether symmetrical or not, is rarely seen in postmenopausal women; hence, these patients should be further investigated or closely followed up

🔖

Bu Makaleye Atıf Yap

ARSLAN, G., ÇELİK, L., ÇUBUK, R., ATASOY, M. M. (2017). Background parenchymal enhancement: is it just an innocent effect of estrogen on the breast?. Diagnostic and Interventional Radiology, Cilt: 23 - Sayı: 6, 414–419. https://ajindex.com/articles/196094

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. Saftlas AF, Hoover RN, Brinton LA, et al. Mam- mographic densities and risk of breast cancer. Cancer 1991; 67:2833–2838. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1159–1169. [CrossRef] Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: develop- ment and validation of a new predictive model. Mammographic density and breast cancer risk: current understanding and future prospects. Ann Intern Med 2008; 148:337–347. [CrossRef] Morris EA, Comstock CE, Lee CH, et al. ACR BI- RADS® Magnetic Resonance Imaging. In: ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. Reston, VA, American College of Radiology; 2013.
  2. Fishman J, Osborne MP, Telang NT. The role of estrogen in mammary carcinogenesis. Ann NY Acad Sci 1995, 768:91–100. [CrossRef] Thomas C, Gustafsson JÅ. The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer 2011; 11:597–608. [CrossRef] Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 2006; 102:89–96. [CrossRef] Lloyd MC, Alfarouk KO, Verduzco D, et al. Vas- cular measurements correlate with estrogen receptor status. BMC Cancer 2014; 14:279. [CrossRef] Dontchos BN, Rahbar H, Partridge SC, et al. Are qualitative assessments of background paren- chymal enhancement, amount of fibroglandu- lar tissue on MR Images, and mammographic density associated with breast cancer risk? Ra- diology 2015; 276:371–380. [CrossRef] King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA. Background parenchymal enhance- ment at breast MR imaging and breast cancer risk. Radiology 2011; 260:50–60. [CrossRef] Giess CS, Yeh ED, Raza S, Birdwell RL. Back- ground parenchymal enhancement at breast MR imaging: normal patterns, diagnostic chal- lenges, and potential for false-positive and false-negative interpretation. Radiographics 2014; 34:234–247. [CrossRef] Bhatelia K, Singh K, Singh R. TLRs: linking in- flammation and breast cancer. Cell Signal 2014; 26:2350–2357. [CrossRef] Kajihara M, Goto M, Hirayama Y, et al. Effect of the menstrual cycle on background parenchy- mal enhancement in breast MR imaging. Magn Reson Med Sci 2013; 12:39–45. [CrossRef] Telegrafo M, Rella L, Stabile Ianora AA, Angelel- li G, Moschetta M. Breast MRI background pa- renchymal en